These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 1684550

  • 1. The potential role of elastase inhibitors in emphysema treatment.
    Eriksson S.
    Eur Respir J; 1991 Oct; 4(9):1041-3. PubMed ID: 1684550
    [No Abstract] [Full Text] [Related]

  • 2. Synthetic elastase inhibitors: prospects for use in the treatment of emphysema.
    Powers JC.
    Am Rev Respir Dis; 1983 Feb; 127(2):S54-8. PubMed ID: 6600895
    [Abstract] [Full Text] [Related]

  • 3. [Elastase, elastase inhibitors and chronic obstructive lung diseases].
    Kramps JA, Dijkman JH.
    Ned Tijdschr Geneeskd; 1990 Jun 09; 134(23):1127-30. PubMed ID: 2192289
    [No Abstract] [Full Text] [Related]

  • 4. Alpha-1-antitrypsin deficiency.
    Idell S, Cohen AB.
    Clin Chest Med; 1983 Sep 09; 4(3):359-75. PubMed ID: 6357600
    [No Abstract] [Full Text] [Related]

  • 5. [Therapy of lung diseases with antiproteases].
    Vogelmeier C, Buhl R.
    Pneumologie; 1994 Feb 09; 48(2):57-62. PubMed ID: 7910401
    [Abstract] [Full Text] [Related]

  • 6. [Possibilities of the prevention and treatment of pulmonary emphysema in the light of the "proteolytic" theory of its pathogenesis].
    Nowak D.
    Pneumonol Pol; 1985 Oct 09; 53(10):492-6. PubMed ID: 3912732
    [No Abstract] [Full Text] [Related]

  • 7. The specific treatment of emphysema.
    Snider GL, Stone PJ, Lucey EC.
    Eur Respir J Suppl; 1990 Mar 09; 9():23s-28s. PubMed ID: 2187448
    [Abstract] [Full Text] [Related]

  • 8. [The evolution of the replacement treatment of emphysema due to alpha 1-antitrypsin deficiency].
    Manresa F.
    Arch Bronconeumol; 1995 Mar 09; 31(7):371-2. PubMed ID: 8777536
    [No Abstract] [Full Text] [Related]

  • 9. Efficacy of augmentation therapy for emphysema associated with α1-antitrypsin deficiency: enough is enough.
    Balbi B, Ferrarotti I, Miravitlles M.
    Eur Respir J; 2016 Jan 09; 47(1):35-8. PubMed ID: 26721962
    [No Abstract] [Full Text] [Related]

  • 10. Selection of a therapeutic agent for the treatment of chronic obstructive pulmonary disease in smokers.
    Turino GM, Davies P, Dunlap R, Krell RD, Maycock AL, Rennard S, Stockley RA.
    Ann N Y Acad Sci; 1991 Dec 31; 624 Suppl():23-30. PubMed ID: 1686162
    [No Abstract] [Full Text] [Related]

  • 11. Opportunities for the development of specific therapeutic agents to treat emphysema.
    Cohen AB.
    Am Rev Respir Dis; 1979 Oct 31; 120(4):723-7. PubMed ID: 389114
    [No Abstract] [Full Text] [Related]

  • 12. Comparison of peptide aldehydes with alpha 1-antitrypsin as elastase inhibitors for use in emphysema.
    Roberts NA, Surgenor AE.
    Biochem Biophys Res Commun; 1986 Sep 30; 139(3):896-902. PubMed ID: 2429659
    [Abstract] [Full Text] [Related]

  • 13. Alpha-1-antitrypsin and other proteinase inhibitors.
    Miravitlles M.
    Curr Opin Pharmacol; 2012 Jun 30; 12(3):309-14. PubMed ID: 22365503
    [Abstract] [Full Text] [Related]

  • 14. Recombinant elastase inhibitors for therapy.
    Schnebli HP.
    Ann N Y Acad Sci; 1991 Jun 30; 624():212-8. PubMed ID: 1676575
    [No Abstract] [Full Text] [Related]

  • 15. [Cigarette smoking and the etiopathogenesis of pulmonary emphysema].
    Górecka D.
    Pneumonol Pol; 1984 Jul 30; 52(7):353-7. PubMed ID: 6387638
    [No Abstract] [Full Text] [Related]

  • 16. [Role of certain mechanisms in the pathogenesis of emphysema and a number of other lung diseases].
    Putov NV, Pokhodzeĭ IV, Kolodkina LA.
    Ter Arkh; 1985 Jul 30; 57(3):144-8. PubMed ID: 3890255
    [No Abstract] [Full Text] [Related]

  • 17. [A study of antielastase activity in the development of pulmonary emphysema in a family with alpha 1-antitrypsin deficiency].
    Kishi F, Kakinoki A.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1989 May 30; 27(5):565-70. PubMed ID: 2615095
    [Abstract] [Full Text] [Related]

  • 18. Recombinant human secretory leukocyte-protease inhibitor: in vitro properties, and amelioration of human neutrophil elastase-induced emphysema and secretory cell metaplasia in the hamster.
    Lucey EC, Stone PJ, Ciccolella DE, Breuer R, Christensen TG, Thompson RC, Snider GL.
    J Lab Clin Med; 1990 Feb 30; 115(2):224-32. PubMed ID: 2299266
    [Abstract] [Full Text] [Related]

  • 19. Neutrophil elastase-mediated lung disease.
    Sandhaus RA, Turino G.
    COPD; 2013 Mar 30; 10 Suppl 1():60-3. PubMed ID: 23527919
    [Abstract] [Full Text] [Related]

  • 20. Alpha 1-PI for emphysema due to alpha 1-antitrypsin deficiency.
    Horowitz ID, Schulman ES.
    Am Fam Physician; 1989 Sep 30; 40(3):223-8. PubMed ID: 2672752
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.